Resources

The UK’s Minster of State for Science, Research, and Innovation, Lord Patrick Vallance, London & Partners’ CEO, Laura Citron OBE, and Steve Bates OBE, CEO of the UK Bioindustry Association (BIA), are formally launching London Life Sciences Week on the UK stand at the BIO International Convention on Tuesday, 17 June 2025.

In this Q&A blog, BIA spoke to Natasha Gray, Associate & Life Sciences Advisory Service Lead at Warn, a new BIA member.

UK life sciences take centre stage at BIO following a promising Spending Review.

A new residential development in North Cambridge is offering science and technology businesses a ready-made solution to one of the city’s most pressing challenges: housing professional staff within easy reach of major employment hubs.

From a multi-billion-pound boost to R&D and life sciences manufacturing, to scaling innovative businesses through the British Business Bank, the Review signals significant investment.

BIA has released a new explainer highlighting why the UK is well-positioned to lead in functional genomics, thanks to its unparalleled research capacity and exceptional talent pool.

Steve Bates OBE, CEO of the UK BioIndustry Association, responded to the government's Spending Review.

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that Dr Robert Tansley is appointed Chief Medical Officer with immediate effect.

Discovery Park has launched applications for its immersive business growth programme, ‘Discovery Spark’, seeking early-stage companies in cardiovascular and cardiometabolic health.

PIR International spoke with experienced life science executive, Bob Radie, as part of there BioLeader interview series.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, shares his insights on BIA's recent Start-up Festival.

An experienced clinician scientist and surgery consultant, Dr Gianmarco Contino brings deep expertise in gastrointestinal cancers and cancer genomics.

Chancellor Rachel Reeves will announce a transformative £86 billion in the Spending Review to turbo-charge our fastest growing sectors, from tech and life sciences, to advanced manufacturing and defence, as part of the government’s plan to invest in Britain’s renewal through our Modern Industrial Strategy.

Positive news ahead of Spending Review (join our webinar this Friday), latest on getting pensions investment into UK life sciences and more!

In this blog, Kate Barclay, Skills Consultant at BIA, introduces Skills England, a new Executive Agency within the Department for Education.

Coulter Partners successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO).

At BIA’s recent Start-up festival, we caught up with Mark Bartlett, CEO of StoreGene, to learn more about his journey, what drives him, and his advice for founders navigating the world of genomics and startups.

In this blog Richard Turner, the new vice chair of FTAC, examines the UK's overhauled R&D tax regime, which provides competitive incentives and a stable fiscal framework.